Winshine Science Company Limited reported no movements in either authorised or issued share capital for April 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 4 May 2026.

Authorised share capital remained at HKD 700.00 million, divided into 70.00 billion ordinary shares with a par value of HKD 0.01 each.

Issued share capital was steady at 1.49 billion ordinary shares, with no treasury shares held or cancelled during the month. Consequently, total issued shares (excluding treasury shares) and total issued shares outstanding both closed the period at 1.49 billion.

Public-float compliance was confirmed, meeting the Main Board’s minimum 25% threshold.

The company’s share option scheme showed: • Outstanding options at month-end: zero • New shares issued under the scheme during April: zero • Potential shares that may be issued under existing option grants: zero • Remaining mandate capacity for future grants: 148.57 million shares

No warrants, convertible securities, or other share-issuance arrangements were reported, and no capital was raised through option exercises.

The disclosure underscores Winshine Science’s stable capital structure, with unchanged share counts and full adherence to Hong Kong listing requirements for the month under review.